Samer Alsaid: Warfarin Outcomes Reassessed Through COMBINE AF
Samer Alsaid, Cardiologist and Vascular Medicine Specialist, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in JACC: Advances, adding:
“Some projects become more than just papers.
Three years ago, my first project at the TIMI Study Group began with a long-standing idea of Dr. Eugene Braunwald.
He had long recognized that we had one of the world’s largest collections of patients treated with warfarin from the pivotal atrial fibrillation trials—and a unique opportunity to answer questions that remain clinically relevant today, including whether there are patients for whom warfarin may still be a reasonable option, particularly where access to DOACs is limited.
Three years later, that work has culminated in two companion papers from the COMBINE AF collaboration, now published in JACC: Advances.
Dr. Braunwald mentored this work every step of the way—with calls, ideas, and thoughtful edits—until the very end.
Sadly, he did not live to see these papers published.
His mentorship, intellectual curiosity, and unwavering commitment to improving patient care will stay with me for the rest of my career.”
Title: Outcomes With Warfarin in Atrial Fibrillation: Individual Patient Data Analysis From Four Randomized Trials
Authors: Samer AlSaid, Eugene Braunwald, Elaine M. Hylek, Michael G. Palazzolo, Andrea Bellavia, Elliott M. Antman, Anthony P. Carnicelli, John W. Eikelboom, Christopher B. Granger, Manesh R. Patel, Lars Wallentin, Christian T. Ruff, Robert P. Giugliano
Read the full article on JACC: Advances.
Title: Heterogeneity of Treatment Effect of DOACs vs Warfarin in Atrial Fibrillation
Authors: Samer Al Said, Andrea Bellavia, Eugene Braunwald, Elaine M. Hylek, Michael G. Palazzolo, Hwanhee Hong, Elliott M. Antman, Anthony P. Carnicelli, John W. Eikelboom, Christopher B. Granger, Manesh R. Patel, Lars Wallentin, Christian T. Ruff, Robert P. Giugliano
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 29, 2026, 16:30Mostafa Faisal: Impact of DNMT3A and TET2 Mutations on Clotting and Bleeding in PV and ET
-
Jul 29, 2026, 16:01Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Jul 29, 2026, 15:42Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
-
Jul 29, 2026, 15:26Ahmad Alkhammash: Completing an Advanced Fellowship in Adult Thrombosis Medicine
-
Jul 29, 2026, 15:13Yara Mahmoud: The Molecular Basis in Hematology
-
Jul 29, 2026, 15:11Louisa Jorm: A New Era of Dynamic Cardiovascular Risk Assessment
-
Jul 29, 2026, 15:04Filippo Consonni: Treatment Strategies for Hematologic Immune Dysregulation in Inborn Errors of Immunity
-
Jul 29, 2026, 14:46François Saller: TFPI-Targeting VHHs for Haemophilia and Rare Bleeding Disorders
-
Jul 29, 2026, 14:29Maria Cherska: Composite Metabolic Markers Could Refine Stroke Prevention